Latest Gustav Gaudernack Stories
TUBINGEN, Germany, October 14, 2014 /PRNewswire/ -- Regulatory authority approves clinical trial for Glioma Actively Personalized
LONDON, Oct. 2, 2014 /PRNewswire/ -- This report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy.
Study Correlates Immune Response with Improved Survival in Prostate Cancer Patients after Receiving the Antigen Express Novel Immunotherapeutic AE37 WORCESTER, Mass.
Astrocytomas and oligodendrogliomas are subtypes of a brain cancer called 'glioma'.
Alex's Lemonade Stand Foundation Supports Cancer Vaccine Research at the University of Maryland. COLLEGE PARK, Md., Jan.
Researchers in the Antibody and Vaccine Group have developed two monoclonal antibodies (mAbs) called anti-4-1BB and anti-CD40 and investigated a third called anti-CTLA-4.